• 2024
  Gaëlle Lièvre, Jonathan Sicsic, Simon Galmiche, Tiffany Charmet, Arnaud Fontanet, Judith Mueller, Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France, Vaccine, 2024, S0264-410X (24), pp.00438-9. ⟨10.1016/j.vaccine.2024.04.024⟩.
• 2023
  Moffroid H, Doglioni DO, Chyderiotis S, Sicsic J, Barret AS, Raude J, Bruel S, Gauchet A, Michel M, Gagneux-Brunon A, Thilly N, Mueller JE, Can physicians and schools mitigate social inequalities in human papillomavirus vaccine awareness, uptake and vaccination intention among adolescents? A cross-sectional study, France, 2021 to 2022., Euro Surveill 2023 Nov; 28(46): .
• 2023
  Yasir Shitu Isa, Jonathan Sicsic, Henry Njuguna, John Ward, Mohamed Chakroun, Mohamed El-Kassas, Rado Ramanampamonjy, Salim Chalal, Jeanne Perpétue Vincent, Monique Andersson, Hailemichael Desalegn, Fatou Fall, Asgeir Johannessen, Philippa Matthews, Gibril Ndow, Edith Okeke, Nicholas Riches, Moussa Seydi, Edford Sinkala, C. Wendy Spearman, Alexander Stockdale, Michael Vinikoor, Gilles Wandeler, Roger Sombié, Maud Lemoine, Judith E. Mueller, Yusuke Shimakawa, Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers, BMC Medicine, 2023, 21 (1), pp.243. ⟨10.1186/s12916-023-02939-y⟩.
• 2022
  Moirangthem S, Olivier C, Gagneux-Brunon A, Péllissier G, Abiteboul D, Bonmarin I, Rouveix E, Botelho-Nevers E, Mueller JE, , Social conformism and confidence in systems as additional psychological antecedents of vaccination: a survey to explain intention for COVID-19 vaccination among healthcare and welfare sector workers, France, December 2020 to February 2021., Euro Surveill 2022 04; 27(17): .
• 2022
  Bonner KE, Ssekyanzi H, Sicsic J, Mueller JE, Toomey T, Ulrich AK, Horvath KJ, Neaton JD, Banura C, Basta NE, , What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda., PLoS One 2022 ; 17(5): e0268063.
• 2021
  Díaz Luévano C, Sicsic J, Pellissier G, Chyderiotis S, Arwidson P, Olivier C, Gagneux-Brunon A, Botelho-Nevers E, Bouvet E, Mueller J, , Quantifying healthcare and welfare sector workers’ preferences around COVID-19 vaccination: a cross-sectional, single-profile discrete-choice experiment in France., BMJ Open 2021 10; 11(10): e055148.
• 2021
  Chyderiotis S, Sicsic J, Raude J, Bonmarin I, Jeanleboeuf F, Le Duc Banaszuk AS, Gauchet A, Bruel S, Michel M, Giraudeau B, Thilly N, Mueller JE, , Optimising HPV vaccination communication to adolescents: A discrete choice experiment., Vaccine 2021 06; 39(29): 3916-3925.
• 2021
  Jean K, Raad H, Gaythorpe KAM, Hamlet A, Mueller JE, Hogan D, Mengistu T, Whitaker HJ, Garske T, Hocine MN, , Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study., PLoS Med 2021 02; 18(2): e1003523.
• 2021
  Godinot LD, Sicsic J, Lachatre M, Bouvet E, Abiteboul D, Rouveix E, Pellissier G, Raude J, Mueller JE, , Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers., Vaccine 2021 01; 39(5): 805-814.
• 2021
  Mueller JE, Seanehia J, Yaro S, Trotter CL, Borrow R, Giles-Vernick T, , Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns., PLoS One 2021 ; 16(7): e0253263.
• 2020
  Escolano S, Mueller JE, Tubert-Bitter P, , Accounting for indirect protection in the benefit-risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018., Euro Surveill 2020 08; 25(33): .
• 2019
  Mueller JE, , Meningococcal strain evolution, dusty dry air and respiratory tract infections: An explosive relationship., EBioMedicine 2019 04; 42(): 34-35.
• 2019
  Mueller JE, , Long-term effectiveness of MenAfriVac., Lancet Infect Dis 2019 03; 19(3): 228-229.
• 2015
  Maïnassara HB, Paireau J, Idi I, Pelat JP, Oukem-Boyer OO, Fontanet A, Mueller JE, Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger, Emerging Infect. Dis. 2015 Aug;21(8):1322-9.
• 2015
  Koutangni T, Boubacar Maïnassara H, Mueller JE, Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis, PLoS ONE 2015;10(2):e0116725.
• 2015
  Blumental S, Moïsi JC, Roalfe L, Zancolli M, Johnson M, Burbidge P, Borrow R, Yaro S, Mueller JE, Gessner BD, Goldblatt D, Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies, Clin. Vaccine Immunol. 2015 Apr;22(4):404-12.
• 2014
  Pivette M, Mueller JE, Crépey P, Bar-Hen A, Drug sales data analysis for outbreak detection of infectious diseases: a systematic literature review, BMC Infect. Dis. 2014;14:604.
• 2014
  Pivette M, Mueller JE, Crépey P, Bar-Hen A, Surveillance of gastrointestinal disease in France using drug sales data, Epidemics 2014 Sep;8:1-8.
• 2014
  Paireau J, Maïnassara HB, Jusot JF, Collard JM, Idi I, Moulia-Pelat JP, Mueller JE, Fontanet A, Spatio-temporal factors associated with meningococcal meningitis annual incidence at the health centre level in Niger, 2004-2010., PLoS Negl Trop Dis 2014 May; 8(5): e2899.
• 2013
  Banke-Thomas AO, Kouraogo SF, Siribie A, Taddese HB, Mueller JE, Knowledge of obstetric fistula prevention amongst young women in urban and rural Burkina Faso: a cross-sectional study, PLoS ONE 2013;8(12):e85921.
• 2013
  Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Traoré Y, Sangaré L, Diagbouga SP, Koeck JL, Borrow R, Gessner BD, Mueller JE, Antipneumococcal seroprevalence and pneumococcal carriage during a meningococcal epidemic in Burkina Faso, 2006, J. Infect. Dis. 2014 Apr;209(8):1241-50.
• 2013
  Comboroure JC, Mueller JE, [Perception of vaccination and role of the pharmacist: A survey among final year pharmacy students in France], Ann Pharm Fr 2014 Mar;72(2):122-31.
• 2013
  Xie O, Pollard AJ, Mueller JE, Norheim G, Emergence of serogroup X meningococcal disease in Africa: need for a vaccine, Vaccine 2013 Jun;31(27):2852-61.
• 2013
  Trotter CL, Yaro S, Njanpop-Lafourcade BM, Drabo A, Kroman SS, Idohou RS, Sanou O, Bowen L, Findlow H, Diagbouga S, Gessner BD, Borrow R, Mueller JE, Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008, PLoS ONE 2013;8(2):e55486.
• 2012
  Gessner BD, Sanou O, Drabo A, Tamekloe TA, Yaro S, Tall H, Moïsi JC, Mueller JE, Njanpop-LaFourcade BM, Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009, Vaccine 2012 Dec;30 Suppl 6:G41-5.
• 2012
  Mueller JE, Yaro S, Ouédraogo MS, Levina N, Njanpop-Lafourcade BM, Tall H, Idohou RS, Sanou O, Kroman SS, Drabo A, Nacro B, Millogo A, van der Linden M, Gessner BD, Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults, PLoS ONE 2012;7(12):e52464.
• 2012
  Mueller JE, Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives, Trop. Med. Int. Health 2013 Jan;18(1):58-64.
• 2012
  Won H, Yang S, Gaydos C, Hardick J, Ramachandran P, Hsieh YH, Kecojevic A, Njanpop-Lafourcade BM, Mueller JE, Tameklo TA, Badziklou K, Gessner BD, Rothman RE, A broad range assay for rapid detection and etiologic characterization of bacterial meningitis: performance testing in samples from sub-Sahara, Diagn. Microbiol. Infect. Dis. 2012 Sep;74(1):22-7.
• 2011
  Mueller JE, Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Diagbouga S, Traoré Y, Sangaré L, Borrow R, Gessner BD, Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity, J. Infect. Dis. 2011 Dec;204(11):1787-95.
• 2011
  Delrieu I, Yaro S, Tamekloé TA, Njanpop-Lafourcade BM, Tall H, Jaillard P, Ouedraogo MS, Badziklou K, Sanou O, Drabo A, Gessner BD, Kambou JL, Mueller JE, Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso, PLoS ONE 2011;6(5):e19513.
• 2010
  Rose AM, Mueller JE, Gerstl S, Njanpop-Lafourcade BM, Page AL, Nicolas P, Traoré RO, Caugant DA, Guerin PJ, Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007, PLoS ONE 2010;5(6):e11086.
• 2010
  Cissé MF, Breugelmans JG, Bâ M, Diop MB, Faye PC, Mhlanga B, Mueller JE, Koffi D, Gessner BD, The Elimination of Haemophilus influenzae type b meningitis following conjugate vaccine introduction in Senegal, Pediatr. Infect. Dis. J. 2010 Jun;29(6):499-503.
• 2010
  Gessner BD, Mueller JE, Yaro S, African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults, BMC Infect. Dis. 2010;10:22.
• 2009
  Mueller JE, Gessner BD, A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt, Int. J. Infect. Dis. 2010 Jul;14(7):e553-9.
• 2009
  Njanpop Lafourcade BM, Sanou O, van der Linden M, Levina N, Karanfil M, Yaro S, Tamekloe TA, Mueller JE, Serotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid, J. Clin. Microbiol. 2010 Feb;48(2):612-4.
• 2009
  Traore Y, Tameklo TA, Njanpop-Lafourcade BM, Lourd M, Yaro S, Niamba D, Drabo A, Mueller JE, Koeck JL, Gessner BD, Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo, Clin. Infect. Dis. 2009 Mar;48 Suppl 2:S181-9.
• 2009
  Mueller JE, Bessaud M, Huang QS, Martinez LC, Barril PA, Morel V, Balanant J, Bocacao J, Hewitt J, Gessner BD, Delpeyroux F, Nates SV, Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina, Appl. Environ. Microbiol. 2009 Mar;75(5):1395-401.
• 2008
  Mueller JE, Yaro S, Madec Y, Somda PK, Idohou RS, Lafourcade BM, Drabo A, Tarnagda Z, Sangaré L, Traoré Y, Fontanet A, Gessner BD, Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso, Trop. Med. Int. Health 2008 Dec;13(12):1543-52.
• 2007
  Muganga N, Uwimana J, Fidele N, Gahimbare L, Gessner BD, Mueller JE, Mhlanga BR, Katsande R, Herbinger KH, Rugambwa C, Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda, Vaccine 2007 Sep;25(39-40):7001-5.
• 2007
  Mueller JE, Sangaré L, Njanpop-Lafourcade BM, Tarnagda Z, Traoré Y, Yaro S, Borrow R, Gessner BD, Nicolas P, Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003, Emerging Infect. Dis. 2007 Jun;13(6):847-54.
• 2007
  Yaro S, Traoré Y, Tarnagda Z, Sangaré L, NjanpopLafourcade BM, Drabo A, Findlow H, Borrow R, Nicolas P, Gessner BD, Mueller JE, Meningococcal carriage and immunity in western Burkina Faso, 2003, Vaccine 2007 Sep;25 Suppl 1:A42-6.
• 2007
  Adjogble KL, Lourd M, Njanpop-Lafourcade BM, Traoré Y, Hlomaschi AF, Amegatse KA, Agbenoko K, Sanou O, Sita K, Mueller JE, Gessner BD, The epidemiology of Neisseria meningitidis meningitis in Togo during 2003-2005, Vaccine 2007 Sep;25 Suppl 1:A47-52.
• 2007
  Findlow H, Vogel U, Mueller JE, Curry A, Njanpop-Lafourcade BM, Claus H, Gray SJ, Yaro S, Traoré Y, Sangaré L, Nicolas P, Gessner BD, Borrow R, Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso, J. Infect. Dis. 2007 Apr;195(7):1071-7.
• 2006
  Traoré Y, Njanpop-Lafourcade BM, Adjogble KL, Lourd M, Yaro S, Nacro B, Drabo A, Parent du Châtelet I, Mueller JE, Taha MK, Borrow R, Nicolas P, Alonso JM, Gessner BD, The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005, Clin. Infect. Dis. 2006 Oct;43(7):817-22.
• 2006
  Daza P, Banda R, Misoya K, Katsulukuta A, Gessner BD, Katsande R, Mhlanga BR, Mueller JE, Nelson CB, Phiri A, Molyneux EM, Molyneux ME, The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence, Vaccine 2006 Sep;24(37-39):6232-9.
• 2006
  Mueller JE, Borrow R, Gessner BD, Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines, Expert Rev Vaccines 2006 Jun;5(3):319-36.
• 2006
  Mueller JE, Yaro S, Traore Y, Sangare L, Tarnagda Z, Njanpop-Lafourcade BM, Borrow R, Gessner BD, Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003, J. Infect. Dis. 2006 Mar;193(6):812-20.
• 2003
  Mueller JE, Frye C, Brasche S, Heinrich J, Association of hormone replacement therapy with bronchial hyper-responsiveness, Respir Med 2003 Aug;97(8):990-2.
• 2003
  Frye C, Mueller JE, Niedermeier K, Wjst M, Heinrich J, Maternal oral contraceptive use and atopic diseases in the offspring, Allergy 2003 Mar;58(3):229-32.
• 2002
  Mueller JE, Döring A, Heier M, Löwel H, Prevalence and determinants of hormone replacement therapy in German women 1984-1995, Maturitas 2002 Oct;43(2):95-104.
• 2000
  Barrett-Connor E, Mueller JE, von Mühlen DG, Laughlin GA, Schneider DL, Sartoris DJ, Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study, J. Clin. Endocrinol. Metab. 2000 Jan;85(1):219-23.
• 1990
  Hoffmann H, Siebeck M, Spannagl M, Weis M, Geiger R, Jochum M, Fritz H, Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs, Am. Rev. Respir. Dis. 1990 Oct;142(4):782-8.